期刊文献+

吡格列酮和胰岛素对内皮祖细胞增殖和凋亡及分泌一氧化氮的影响 被引量:1

Effects of insulin and pioglitazone on proliferation,apoptosis and NO secretion of endothelial progenitor cells
暂未订购
导出
摘要 目的观察吡格列酮和胰岛素对大鼠骨髓内皮祖细胞(EPCs)的增殖能力、凋亡及分泌NO能力的影响,并探讨其机制。方法取正常SD大鼠32只,随机分为吡格列酮组和非吡格列酮组,各16只,分别给予吡格列酮和生理盐水灌胃预处理。喂养10天后,断颈处死,密度梯度离心法取骨髓单个核细胞,在M199培养液中培养扩增EPCs并进行鉴定。贴壁细胞培养4天后,将吡格列酮组EPCs消化后进一步分为两组,分别给予胰岛素(1nmol/L)或空白干预,非吡格列酮组EPCs处理同吡格列酮组EPCs。24h后检测NO水平,3天后检测凋亡情况,7天后检测细胞增殖能力。结果吡格列酮预处理能提高EPCs数量(P<0.01),吡格列酮预处理和(或)体外给予胰岛素干预组EPCs与未处理组细胞相比EPCs增殖能力提高(P<0.01),凋亡程度降低(P<0.05),培养上清中NO浓度增加(P<0.05)。结论体内吡格列酮预处理与体外胰岛素干预均能促进EPCs增殖,抑制EPCs凋亡,并促进EPCs分泌NO,且两种药物联合应用具有协同作用。 Objective To investigate the effects of pioglitazone and insulin on proliferation,apoptosis and nitric oxide (NO) secretion of endothelial progenitor cells (EPCs) derived from bone marrow. Methods Thirty-two SD rats were randomly divided into pioglitazone group,which was given pioglitazone (20 mg·kg^-1 ·d^-1) by intragastric administration for 10 d,and non- pioglitazone group,which was given physiologic saline(0. 9%)of the same volume. Each group included 16 rats. Mononuclear cells were collected from rats' bone marrow by density gradient centrifugation, cultured with M 199 medium,and identified by UEA-I and ac-LDL staining. Of them the double positive ones were EPCs. Once harvested, EPCs of both groups were given vehicle or insulin (1 nmol/L) respectively. After 24 h of incubation, NO secretion of EPCs was measured by the Griess assay with spectrophotometer. After incubation for 3 d,apoptosis was detected by FCM. After 7 d of incubation,proliferation capacity was measured by MTT assay. Results Pioglitazone given in vivo could increase the number of EPCs. Compared with the control group, pioglitazone and insulin group,insulin group and pioglitazone group respectively showed higher proliferation capacity( P 〈0.01 ), lower EPCs apoptosis ( P 〈0.05), and more NO production ( P 〈0.05). Conclusion Both pioglitazone given in vivo and insulin given in vitro can stimulate EPCs proliferation,decrease its apoptosis,and promote its secretion of NO,and these two kinds of intervention have synergistic effects.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2008年第3期202-205,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 胰岛素 血管内皮生长因子类 一氧化氮 细胞增殖 细胞凋亡 吡格列酮 内皮祖细胞 insulin vascular endothelial growth factors nitric oxide cell proliferation apoptosis pioglitazone endothelial progenitor cells
  • 相关文献

参考文献11

  • 1Hristov M, Erl W,Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol, 2003,23:1185-1189.
  • 2Werner N,Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med,2006,10:318-332.
  • 3Vasa M,Fichtlscherer S, Aicher A, et al, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res,2001,89:E1-E7.
  • 4Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation,adhesion,and incorporation into vascular structures. Circulation, 2002,106 : 2781-2786.
  • 5Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med, 2003,9 : 1370-1376.
  • 6Gensch C,Clever Y,Werner C,et al. The PPAR-7 agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis, 2007, 192:67- 74.
  • 7Ikeda U,Shimpo M,Murakami Y,et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells. Hypertension, 2000, 35:1232-1236.
  • 8Hwang J ,Kleinhenz DJ, Lassegue B, et al. Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production. Am J Physiol cell Physiol,2005, 288 : C899-C905.
  • 9Urbich C, Dimmeler S. Risk factors for coronary artery disease,circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney International, 2005, 67:1672.
  • 10楚罗湘,姜德谦,刘照云.吡格列酮对人脐静脉内皮细胞CD40/CD40L表达的影响[J].中国药物与临床,2006,6(1):48-51. 被引量:4

二级参考文献32

  • 1吴歆华,吴宗贵,张华.辛伐他汀与罗格列酮对动脉粥样硬化大鼠CD40和CD40L表达的影响[J].上海医学,2005,28(4):281-283. 被引量:6
  • 2Mehta JL, Li DY. Identification and autoregulation of receptor for oxLDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun, 1998,248:511-514.
  • 3Hakkinen T, Karkola K, Yla-Herttuala S. Macrophages, smooth muscle cells,endothelial cells,and T-cells express CD40 and CD4OL in fatty streaks and more advanced human atherosclerotic lesions: colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaR Ⅲ). Virchows Arch,2000, 437: 396-405.
  • 4Hessler JR,Morel DW,Lewis LJ,et al.Lipoprotein oxidation and lipoprotein-indueed cytotoxicity. Atheresclerosis,1983,3:215-222.
  • 5Sehonbeck U, Sukhova GK, Sehonbeck U, et al. Inhibition of CD40 signaling limits evolution established atherosclerosis in mice. Proc Natl Acad Sci USA,2000,97:7458-7463.
  • 6Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells.Circulation,2000,101:2889-2895.
  • 7Li DY, Jawahar L. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells evidence from use of antisense LOX-1 mRNA and chemical inhibitors.Arterioscler Thromb Vase Biol, 2000,20:1116-1122.
  • 8Garlichs CD,John S,Sehmeisser A, et al. Upregulation of CD40 and CD40 ligand (CD154)in patients with moderate hypercholesterolemia .Circulation,2001,104:2395 -2400.
  • 9Lemberger T, Desvergne B,Wahli W. Peroxisome proliferator-activated receptors:a muclear receptor signaling pathway in lipid physiology.Annu Rev Cell Dev Bio1,1996,12:335-363.
  • 10Jawahar L, Hu B,Chen JW, et al. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vaac Biol,2003,23:2203 -2208.

共引文献7

同被引文献5

  • 1李焱.炎症、胰岛素抵抗是2型糖尿病和动脉粥样硬化的共同基础[J].国外医学(内分泌学分册),2005,25(3):150-152. 被引量:48
  • 2Werner C,Kamani C H,Gensch C,et al.The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance[J].Diabetes,2007,56(10):2 609-2 615.
  • 3Harald Sourij,Robert Zweiker,Thomas C,et al.Effects of pioglitazone on endothelial function,insulin sensitivity,and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes[J].Diabetes Care,2006,29 (5):1 039-1 045.
  • 4Maegawa H,Nishio Y,Nakao K,et al.Short-term low-dosage pioglitazone treatment improves vascular dysfunction in patients with type 2 diabetes[J].Endocr J,2007,54 (4):613-618.
  • 5Urbich C,Dimmeler S.Risk factors for coronary artery dis2ease,circulating endot helial progenitor cells,and t he role of HMG2CoA reductase inhibitors[J].Kidney International,2005,67:1 672.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部